# Tigecycline

NDC: 0781-3481
Generic name: Tigecycline
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, PARENTERAL
Marketing started: 20171130

FDA application: ANDA091620

## Active ingredients

- TIGECYCLINE: 50 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-3481"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-3481
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50605463-2dc2-4b27-bc51-4d87bb9a8539